Tuesday, 22 May 2012

The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees. The biopharmaceutical licensing industry is growing in popularity as large companies are becoming heavily dependent on alliances and licensing to gain access to newer technologies in the biopharmaceutical market.

This dependence has strengthened the bargaining position of smaller players as they are willing to expand their role beyond product discovery and development towards active participation in the biopharmaceutical products industry. 
This research report on the biopharmaceutical licensing market analyzes its market segments and major geographies. The major regions analyzed under this research study are 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World 
This report provides a comprehensive analysis of market trends, industry growth drivers, restraints, market structure, and market projections for the coming years. It also includes an analysis of the technological developments in the biopharmaceutical licensing industry, Porter’s five force model analysis, and detailed company profiles of the top industry players. It provides a review of the micro and macro factors significant for the existing market players and new entrants along with detailed value chain analysis. 
Key players dominating this industry are Intas Pharmaceuticals Ltd., Pfizer, Merck & Co., GlaxoSmithKline, Johnson & Johnson, Bayer AG, Novartis, Hoffman La-Roche, Sanofi, AstraZeneca, Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly & Company, Schering-Plough, Baxter International, Genentech, Proctor & Gamble, Boehringer Ingelheim, and others.

Reasons for Buying this Report 
  • This research report provides an overview of the different factors responsible for driving and limiting market growth 
  • It provides a complete analysis of the major competitors and their business strategies and helps to get a proper insight of the market
  • It helps to make informed business decisions based on the in-depth analysis of industry trends 
  • It provides a clear understanding of the key product segments and helps to stay ahead in the competition 
  • It provides a technological growth map over a time and explains its impact on the market 
Read More with Full TOC :  http://www.transparencymarketresearch.com/biopharmaceutical-licensing-market.html

Wednesday, 16 May 2012

The current trend of shifting patients from hospitals to home healthcare is giving rise to professional home healthcare service providing agencies and firms. The shift from conventional treatment to proactive monitoring is opening up new opportunities in the home Healthcare market. Patients prefer such services mainly because of convenience and cost effectiveness. Third party healthcare service is also in growing demand due to better quality of treatment provided by trained professionals.

Browse : Home Healthcare Market

Home Healthcare services are provided by healthcare professionals to patients at their own homes. These services are also called formal or skilled care services. Respiratory therapy, rehabilitation services, home infusion therapy, unskilled home care, telehealth, etc. are some major home Healthcare services provided.

Home Healthcare Market Segmentation 

Home Healthcare market segmentation is based on the Healthcare services provided:

Home-based Pulmonary Care
Home Infusion Therapy
Respiratory Therapy
Unskilled Home Healthcare

This market research report analyzes home Healthcare market based on different segments and major regions. It is a complete study of current market trends, recent developments, factors affecting market growth and restraints. The report also provides information on technological advancements in the Healthcare industry, Porter’s five force analysis, and detailed profiles of top industry players. It includes a review of the micro and macro factors significant for the existing market players and new entrants along with detailed value chain analysis.

The major regions analyzed under this market research study are North America, the Asia-Pacific, Europe, and the Rest of the World.

The major players in this industry are 3M Healthcare, Abbott Laboratories, Alere Medical Inc., Amedisys Inc., Air Liquide, Almost Family Inc., Apria Healthcare Group, Arcadia Resources Inc., Baxter International Inc., B. Braun Melsungen AG, Arkray Inc., Bayer Healthcare AG, Biotronik SE & Co. KG, Critical Home Care, Chubb Community Care, Cardinal Health Inc., Becton, Dickinson and Company (BD), GE Healthcare, Gambro AB, Fresenius SE, Gentiva Health Services Inc., Graham-Field Health Products Inc., Invacare, Kinetic Concepts, Lincare Holdings Inc., Linde Healthcare, and others.

Reasons for Buying this Report
This report provides a comprehensive analysis of major competitors and their market strategies
It gives information about innovative product development and market forecast
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It gives a complete understanding of the key product segments
It provides pin-point analysis of changing competition dynamics to help in making more informed business decisions
It provides forward looking perspectives on the different factors affecting and driving market growth

Read More with TOC: http://www.transparencymarketresearch.com/home-healthcare-market.html